On July 21, 2025, Needham analyst Gil Blum reiterated a 'Buy' rating on Autolus Therapeutics (AUTL, Financial). The rating remains unchanged from the analyst's prior assessment.
The price target for Autolus Therapeutics (AUTL, Financial) is maintained at USD 10.00. This target reflects no change from the previous price target and underscores the analyst's consistent outlook on the company's potential.
Autolus Therapeutics (AUTL, Financial) continues to garner attention as Needham remains steadfast in its positive outlook for the company's future performance. The unchanged price target and rating highlight consistent confidence in the company's strategic direction.
Investors in Autolus Therapeutics (AUTL, Financial) can refer to Gil Blum's analysis and recommendations for further insight into the stock's performance and future prospects.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 10 analysts, the average target price for Autolus Therapeutics PLC (AUTL, Financial) is $9.67 with a high estimate of $13.00 and a low estimate of $5.70. The average target implies an upside of 279.96% from the current price of $2.55. More detailed estimate data can be found on the Autolus Therapeutics PLC (AUTL) Forecast page.
Based on the consensus recommendation from 11 brokerage firms, Autolus Therapeutics PLC's (AUTL, Financial) average brokerage recommendation is currently 1.6, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Autolus Therapeutics PLC (AUTL, Financial) in one year is $26.23, suggesting a upside of 930.65% from the current price of $2.545. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Autolus Therapeutics PLC (AUTL) Summary page.
